Respiratory syncytial virus (RSV) infection is the leading cause of hospitalisation ... The North region (16,983,485 inhabitants) has an equatorial climate with rainfall throughout the year (monthly ...

Report Ocean has published a new report on the Saudi Arabia Respiratory Disease Vaccine Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities.

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

NEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has ...